Wuhan Wansheng Biotechnology
Finnrick has tested 191 samples from Wuhan Wansheng Biotechnology across 9 products.
Fraud: Based on community reports, we have identified wuhanwanshengbio.com as a fraudulent web site aggressively operating in the name of this vendor. It is most likely entirely unaffiliated with the original company, the fraud is putting the public at risk, so we are temporarily putting all tests under review.
Finnrick Vendor Profile
Wuhan Wansheng Biotechnology
Tracking 9 products
191 total samples tested
Last test 25 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| BPC-157 | 15 | 18 Sep 2025 | 2 Mar 2026 | |||||
| Cagrilintide | 13 | 21 Oct 2025 | 25 Feb 2026 | |||||
| CJC-1295 | 6 | 29 Oct 2025 | 18 Feb 2026 | |||||
| GHK-Cu | 18 | 4 Aug 2025 | 10 Feb 2026 | |||||
| Ipamorelin | 12 | 11 Aug 2025 | 26 Feb 2026 | |||||
| Retatrutide | 55 | 4 Aug 2025 | 3 Mar 2026 | |||||
| TB-500 | 6 | 4 Aug 2025 | 25 Mar 2026 | |||||
| Tesamorelin | 22 | 11 Aug 2025 | 4 Mar 2026 | |||||
| Tirzepatide | 43 | 31 Aug 2025 | 25 Mar 2026 | |||||
The Wuhan Wansheng Biotechnology samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent Wuhan Wansheng Biotechnology tests
Samples are tested in commercial labs
191
tests
9
products
Scores
AVGMINMAX
First
4 Aug 2025
Last
25 Mar 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 25 Mar 2026⚠️ | Tirzepatide | View | 100mg | 32.1mg | -67.9% | 99.90% | 02/26 | No Label / Black Crimp / Clear Cap | Lab G | Public | |
| 25 Mar 2026⚠️ | TB-500 | View | 10mg | 13.4mg | +34.0% | 99.60% | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 4 Mar 2026⚠️ | Tesamorelin | View | 10mg | 10.8mg | +8.0% | 99.72% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 3 Mar 2026⚠️ | Retatrutide | View | 30mg | 26.6mg | -11.3% | 99.52% | RT30 | No Label / Black Crimp / Clear Red Cap | Lab E | Public | |
| 2 Mar 2026⚠️ | Tesamorelin | View | 10mg | ⚠️ Sample does not contain Tesamorelin | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | |||
| 2 Mar 2026⚠️ | Tesamorelin | View | 5mg | 22.2mg | +344.0% | 99.90% | (no batch ID) | No Label / Red Crimp / White Cap | Lab E | Public | |
| 2 Mar 2026⚠️ | Retatrutide | View | 10mg | 9.63mg | -3.7% | 99.90% | PL2026 | White Label / Red Crimp / Black Cap | Lab E | Public | |
Corrections
- 5 Nov 2025: Retatrutide
- These were remade and reanalyzed by Lab G. They traced the discrepancy to a likely human error during preparation.